Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
ICLN has surged about 45% year-to-date, signaling a regime shift from subsidy bets to infrastructure demand. A loomin...
When a billionaire investor opens a new fund, it sends ripples through markets. Bill Ackman just gave investors a fre...
A blockbuster IPO can set the stage for more funding moves. This article explains why spacex raising more cash throug...
Investors are tilting toward Argentina’s reform story via a single-country ETF, while broad Latin America funds like ...
When a prominent investor trims a large stake, the market often swings. This piece breaks down what happened with Aca...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
A bold move in the crypto mining world is steering toward artificial intelligence compute. This article examines what...
Seven U.S. spot XRP ETFs have drawn $1.44B since late 2025, but XRP’s price remains volatile as inflows outpace gains.
As CleanSpark gears up for its 2026 earnings season, investors wonder how mining economics, energy initiatives, and c...
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
Bitcoin extended a retreat as investors moved cash from crypto into equities ahead of SpaceX's anticipated mega IPO. ...